The Effects of Ischemic Preconditioning on Human Exercise Performance

Sports Medicine

Volumn 46, Issue 4, 2016, Pages 531-544

  Incognito, Anthony V ^a   Burr, Jamie F ^a   Millar, Philip J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; CINAHL; EXERCISE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC PRECONDITIONING; LACTATE BLOOD LEVEL; MEDLINE; OXYGEN CONSUMPTION; PHENOTYPE; SAMPLE SIZE; SPORT; SYSTEMATIC REVIEW; ATHLETIC PERFORMANCE; BLOOD; CARDIORESPIRATORY FITNESS; EXERCISE TEST;

LACTIC ACID;

ATHLETIC PERFORMANCE; CARDIORESPIRATORY FITNESS; EXERCISE; EXERCISE TEST; HUMANS; ISCHEMIC PRECONDITIONING; LACTIC ACID; OXYGEN CONSUMPTION;

EID: 84949514513     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-015-0433-5     Document Type: Review

References (83)

1. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, et al. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol. 2005;46:450–6.
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–36.
3. Shimizu M, Tropak M, Diaz RJ, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond). 2009;117:191–200.
4. Przyklenk K, Bauer B, Ovize M, et al. Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87:893–9.
5. Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010;375:727–34.
6. Candilio L, Malik A, Ariti C, et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart. 2015;101:185–92.
7. Walsh SR, Tang TY, Kullar P, et al. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg. 2008;34:985–94.
8. Addison PD, Neligan PC, Ashrafpour H, et al. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol. 2003;285:H1435–43.
9. Pang CY, Yang RZ, Zhong A, et al. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res. 1995;29:782–8.
10. Schroeder CA Jr, Lee HT, Shah PM, et al. Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury. J Surg Res. 1996;63:29–34.
11. Lintz JA, Dalio MB, Joviliano EE, et al. Ischemic pre and postconditioning in skeletal muscle injury produced by ischemia and reperfusion in rats. Acta Cir Bras. 2013;28:441–6.
12. Enko K, Nakamura K, Yunoki K, et al. Intermittent arm ischemia induces vasodilatation of the contralateral upper limb. J Physiol Sci. 2011;61:507–13.
13. Horiuchi M, Endo J, Thijssen DH. Impact of ischemic preconditioning on functional sympatholysis during handgrip exercise in humans. Physiol Rep. 2015;3:e12304.
14. Bailey TG, Birk GK, Cable NT, et al. Remote ischemic preconditioning prevents reduction in brachial artery flow-mediated dilation after strenuous exercise. Am J Physiol Heart Circ Physiol. 2012;303:H533–8.
15. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106:2881–3.
16. Wang WZ, Stepheson LL, Fang XH, et al. Ischemic preconditioning-induced microvascular protection at a distance. J Reconstr Microsurg. 2004;20:175–81.
17. de Groot PC, Thijssen DH, Sanchez M, et al. Ischemic preconditioning improves maximal performance in humans. Eur J Appl Physiol. 2010;108:141–6.
18. Jean-St-Michel E, Manlhiot C, Li J, et al. Remote preconditioning improves maximal performance in highly trained athletes. Med Sci Sports Exerc. 2011;43:1280–6.
19. Bailey TG, Jones H, Gregson W, et al. Effect of ischemic preconditioning on lactate accumulation and running performance. Med Sci Sports Exerc. 2012;44:2084–9.
20. Kilduff LP, Finn CV, Baker JS, et al. Preconditioning strategies to enhance physical performance on the day of competition. Int J Sports Physiol Perform. 2013;8:677–81.
21. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–34.
22. Stewart LA, Clarke M, Rovers M, et al. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. JAMA. 2015;313:1657–65.
23. Heusch G. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 2015;116:674–99.
24. Gastin PB. Energy system interaction and relative contribution during maximal exercise. Sports Med. 2001;31:725–41.
25. Clevidence MW, Mowery RE, Kushnick MR. The effects of ischemic preconditioning on aerobic and anaerobic variables associated with submaximal cycling performance. Eur J Appl Physiol. 2012;112:3649–54.
26. Cruz RS, De Aguiar RA, Turnes T, et al. Effects of ischemic preconditioning on maximal constant load cycling performance. J Appl Physiol (1985) 2015;119:961–7.
27. Gibson N, White J, Neish M, et al. Effect of ischemic preconditioning on land-based sprinting in team-sport athletes. Int J Sports Physiol Perform. 2013;8:671–6.
28. Kido K, Suga T, Tanaka D, et al. Ischemic preconditioning accelerates muscle deoxygenation dynamics and enhances exercise endurance during the work-to-work test. Physiol Rep. 2015;3:e12395.
29. Tocco F, Marongiu E, Ghiani G, et al. Muscle ischemic preconditioning does not improve performance during self-paced exercise. Int J Sports Med. 2015;36:9–15.
30. Marocolo M, da Mota GR, Pelegrini V, et al. Are the beneficial effects of ischemic preconditioning on performance partly a placebo effect? Int J Sports Med. 2015;36:822–5.
31. Kjeld T, Rasmussen MR, Jattu T, et al. Ischemic preconditioning of one forearm enhances static and dynamic apnea. Med Sci Sports Exerc. 2014;46:151–5.
32. Marocolo M, Willardson JM, Marocolo IC, et al. Ischemic preconditioning and placebo intervention improves resistance exercise performance. J Strength Cond Res. PMID: 26466134. doi:10.1519/JSC.0000000000001232.
33. Crisafulli A, Tangianu F, Tocco F, et al. Ischemic preconditioning of the muscle improves maximal exercise performance but not maximal oxygen uptake in humans. J Appl Physiol. 1985;2011(111):530–6.
34. Barbosa TC, Machado AC, Braz ID, et al. Remote ischemic preconditioning delays fatigue development during handgrip exercise. Scand J Med Sci Sports. 2015;25:356–64.
35. Foster GP, Westerdahl DE, Foster LA, et al. Ischemic preconditioning of the lower extremity attenuates the normal hypoxic increase in pulmonary artery systolic pressure. Respir Physiol Neurobiol. 2011;179:248–53.
36. Patterson SD, Bezodis NE, Glaister M, et al. The effect of ischemic preconditioning on repeated sprint cycling performance. Med Sci Sports Exerc. 2015;47:1652–8.
37. Gibson N, Mahony B, Tracey C, et al. Effect of ischemic preconditioning on repeated sprint ability in team sport athletes. J Sports Sci. 2015;33:1182–8.
38. Lalonde F, Curnier DY. Can anaerobic performance be improved by remote ischemic preconditioning? J Strength Cond Res. 2015;29:80–5.
39. Paixão RC, da Mota GR, Marocolo M. Acute effect of ischemic preconditioning is detrimental to anaerobic performance in cyclists. Int J Sports Med. 2014;35:912–5.
40. Hittinger EA, Maher JL, Nash MS, et al. Ischemic preconditioning does not improve peak exercise capacity at sea level or simulated high altitude in trained male cyclists. Appl Physiol Nutr Metab. 2015;40:65–71.
41. El Messaoudi S, Vissers A, Thijssen D, et al. The effect of remote ischemic preconditioning on exercise-induced plasma troponin I appearance in healthy volunteers. Int J Cardiol. 2013;168:1612–3.
42. Jones H, Nyakayiru J, Bailey TG, et al. Impact of eight weeks of repeated ischaemic preconditioning on brachial artery and cutaneous microcirculatory function in healthy males. Eur J Prev Cardiol. 2015;22:1083–7.
43. Patterson SD, Bezodis NE, Glaister M, et al. The effect of ischemic preconditioning on repeated sprint cycling performance. Med Sci Sports Exerc. 2014;47:1652–8.
44. Battipaglia I, Scalone G, Milo M, et al. Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease. Heart. 2011;97:1298–303.
45. Koch S, Della-Morte D, Dave KR, et al. Biomarkers for ischemic preconditioning: finding the responders. J Cereb Blood Flow Metab. 2014;34:933–41.
46. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc. 2001;33:S446–51.
47. Brevoord D, Kranke P, Kuijpers M, et al. Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis. PLoS One. 2012;7:e42179.
48. Lee TM, Su SF, Chou TF, et al. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation. 2002;105:334–40.
49. Laskey WK, Beach D. Frequency and clinical significance of ischemic preconditioning during percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:998–1003.
50. Sharma V, Cunniffe B, Verma AP, et al. Characterization of acute ischemia-related physiological responses associated with remote ischemic preconditioning: a randomized controlled, crossover human study. Physiol Rep. 2014;2:e12200.
51. Loukogeorgakis SP, Williams R, Panagiotidou AT, et al. Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation. 2007;116:1386–95.
52. Hausenloy DJ, Yellon DM. The second window of preconditioning (SWOP) where are we now? Cardiovasc Drugs Ther. 2010;24:235–54.
53. Lalonde F, Poirier P, Arvisais D, et al. Exercise-induced ischemic preconditioning and the potential application to cardiac rehabilitation: a systematic review. J Cardiopulm Rehabil Prev. 2015;35:93–102.
54. Niccoli G, Altamura L, Fabretti A, et al. Ethanol abolishes ischemic preconditioning in humans. J Am Coll Cardiol. 2008;51:271–5.
55. Riksen NP, Zhou Z, Oyen WJ, et al. Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol. 2006;48:700–7.
56. Perera V, Gross AS, Xu H, et al. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics. J Pharm Pharmacol. 2011;63:1161–8.
57. Jacobsen D, Sebastian CS, Dies DF, et al. Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans. Alcohol Clin Exp Res. 1996;20:804–9.
58. Burke LM. Caffeine and sports performance. Appl Physiol Nutr Metab. 2008;33:1319–34.
59. Liem DA, Verdouw PD, Ploeg H, et al. Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol Heart Circ Physiol. 2002;283:H29–37.
60. Steensrud T, Li J, Dai X, et al. Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine. Am J Physiol Heart Circ Physiol. 2010;299:H1598–603.
61. Redington KL, Disenhouse T, Strantzas SC, et al. Remote cardioprotection by direct peripheral nerve stimulation and topical capsaicin is mediated by circulating humoral factors. Basic Res Cardiol. 2012;107:241.
62. Moses MA, Addison PD, Neligan PC, et al. Mitochondrial KATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol. 2005;288:H559–67.
63. Mansour Z, Bouitbir J, Charles AL, et al. Remote and local ischemic preconditioning equivalently protects rat skeletal muscle mitochondrial function during experimental aortic cross-clamping. J Vasc Surg. 2012;55(497–505):e1.
64. Thaveau F, Zoll J, Rouyer O, et al. Ischemic preconditioning specifically restores complexes I and II activities of the mitochondrial respiratory chain in ischemic skeletal muscle. J Vasc Surg. 2007;46:541–7 (discussion 7).
65. Costa F, Christensen NJ, Farley G, et al. NO modulates norepinephrine release in human skeletal muscle: implications for neural preconditioning. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1494–8.
66. Pudupakkam S, Harris KA, Jamieson WG, et al. Ischemic tolerance in skeletal muscle: role of nitric oxide. Am J Physiol. 1998;275:H94–9.
67. Rassaf T, Totzeck M, Hendgen-Cotta UB, et al. Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res. 2014;114:1601–10.
68. Larsen FJ, Schiffer TA, Borniquel S, et al. Dietary inorganic nitrate improves mitochondrial efficiency in humans. Cell Metab. 2011;13:149–59.
69. Seyfarth M, Richardt G, Mizsnyak A, et al. Transient ischemia reduces norepinephrine release during sustained ischemia. Neural preconditioning in isolated rat heart. Circ Res. 1996;78:573–80.
70. Kimura M, Ueda K, Goto C, et al. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2007;27:1403–10.
71. Saes GF, Zerati AE, Wolosker N, et al. Remote ischemic preconditioning in patients with intermittent claudication. Clinics (Sao Paulo). 2013;68:495–9.
72. Delagarde H, Ouadraougo N, Grall S, et al. Remote ischaemic preconditioning in intermittent claudication. Arch Cardiovasc Dis. 2015;108:472–9.
73. Slagsvold KH, Rognmo O, Hoydal M, et al. Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ Res. 2014;114:851–9.
74. Slagsvold KH, Moreira JB, Rognmo O, et al. Remote ischemic preconditioning preserves mitochondrial function and activates pro-survival protein kinase Akt in the left ventricle during cardiac surgery: a randomized trial. Int J Cardiol. 2014;177:409–17.
75. Shimizu M, Konstantinov IE, Kharbanda RK, et al. Effects of intermittent lower limb ischaemia on coronary blood flow and coronary resistance in pigs. Acta Physiol (Oxf). 2007;190:103–9.
76. Zhou K, Yang B, Zhou XM, et al. Effects of remote ischemic preconditioning on the flow pattern of the left anterior descending coronary artery in normal subjects. Int J Cardiol. 2007;122:250–1.
77. McDonald MA, Braga JR, Li J, et al. A randomized pilot trial of remote ischemic preconditioning in heart failure with reduced ejection fraction. PLoS One. 2014;9:e105361.
78. Seeger JP, Benda NM, Riksen NP, et al. Heart failure is associated with exaggerated endothelial ischaemia-reperfusion injury and attenuated effect of ischaemic preconditioning. Eur J Prev Cardiol. PMID: 25389072. doi:10.1177/2047487314558377.
79. Faselis C, Doumas M, Pittaras A, et al. Exercise capacity and all-cause mortality in male veterans with hypertension aged ≥70 years. Hypertension. 2014;64:30–5.
80. La Rovere MT, Pinna GD, Maestri R, et al. The 6-minute walking test and all-cause mortality in patients undergoing a post-cardiac surgery rehabilitation program. Eur J Prev Cardiol. 2015;22:20–6.
81. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801.
82. O’Connor CM, Whellan DJ, Wojdyla D, et al. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model. Circ Heart Fail. 2012;5:63–71.
83. Keteyian SJ, Leifer ES, Houston-Miller N, et al. Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol. 2012;60:1899–905.